ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

CMS and health insurance reimbursement remains elusive for new medical device technologies





Market Access Experts, a specialized consultancy firm, announces its new services aimed at helping medical device manufacturers secure accelerated and optimal reimbursement for their innovative technologies.

PHOENIX, AZ, February 25, 2025 /24-7PressRelease/ -- With over 25 years of experience in medical coding, market access, and reimbursement for implantable devices, the company is dedicated to guiding clients through the complex reimbursement process involving the Centers for Medicare & Medicaid Services (CMS) and private payors.

Many medical device startups focus primarily on obtaining FDA approval, often overlooking the crucial aspect of medical device reimbursement. Market Access Experts addresses this gap by offering strategic solutions designed to reduce barriers to market adoption and accelerate patient access to life-changing medical technologies.

Expanding Market Access for Medical Innovations

"Reimbursement is a key factor in the success of medical devices, yet it remains one of the most challenging hurdles for device manufacturers', states David Davis, CEO. Market Access Experts provides expert guidance on securing proper coding, favorable coverage policies, and appropriate payment levels, ensuring that even the most advanced medical innovations can reach patients in need.

The firm's tailored strategies help companies avoid common pitfalls, streamline the approval process, and navigate the evolving landscape of healthcare reimbursement. By aligning reimbursement efforts with regulatory approvals, Market Access Experts enhances commercialization efforts and ensures financial sustainability for medical device manufacturers.

Addressing Industry Challenges with Expertise

The medical technology industry faces significant challenges in gaining reimbursement approvals, particularly as regulatory requirements and payor expectations continue to evolve. Market Access Experts offers a comprehensive approach that integrates regulatory pathways with market access strategies, ensuring a smooth transition from product development to commercialization.

The company also assists clients in engaging key stakeholders, including healthcare providers, payors, and policymakers, to build strong support networks that facilitate successful market entry. This proactive engagement is essential for fostering trust and collaboration, ultimately increasing the likelihood of reimbursement approval.

Customized Solutions for Long-Term Success

Market Access Experts takes a customized approach to each client, recognizing that every medical device is unique. The firm conducts in-depth market analyses, identifies potential challenges, and develops strategic plans tailored to each product's specific needs.

With a focus on sustainability, Market Access Experts helps companies secure long-term reimbursement solutions that support continued growth and patient access. By leveraging its extensive industry expertise, the firm ensures that medical device manufacturers are well-positioned for commercial success.

About Market Access Experts
Market Access Experts is a specialized consultancy dedicated to supporting medical device manufacturers in achieving optimal reimbursement for their innovative technologies. With over 25 years of experience in medical coding, market access, and implantable devices, the firm guides clients through the complex reimbursement landscape involving both CMS and private payors. Their mission is to reduce barriers to market adoption and accelerate patient access to life-changing medical devices, ensuring sustainable reimbursement and long-term commercial success.

---
Press release service and press release distribution provided by https://www.24-7pressrelease.com
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.